Biogen's Alzheimer's Drug Slows Decline in Trial

A new Alzheimer's treatment from Biogen showed promising results by slowing cognitive decline at rates similar to already approved therapies.

The drug works differently than existing treatments by targeting tau proteins that form toxic tangles in the brain.